Close

CD70

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Product List Background Anti-CD70 CAR-T Services Anti-CD70 CAR-T In Vitro Assay ServicesAnti-CD70 CAR-T In Vivo Assay Services

Product List

Creative Biolabs offers a wide range of products and services related to CD70 CAR-T cells, catering to various needs and requirements. We also provide comprehensive customization services. Our team of experts works closely with clients to develop personalized CD70 CAR-T cell products tailored to their specific research or treatment goals. Contact us and let us help you in your journey towards groundbreaking discoveries in the research of CD70 CAR-T cells.

Background

CD70, also known as cluster of differentiation 70, serves as a ligand for CD27, a TNFR (tumor necrosis factor receptor) superfamily type I transmembrane glycoprotein. CD70 specifically binds to CD27, which is expressed by activated T and B lymphocytes as well as mature dendritic cells. CD70 is a promising target for antibody-based therapies.

Associated Diseases

Expression of CD70 on human tumor tissues. Fig.1 Expression of CD70 on human tumor tissues.1

Anti-CD70 CAR-T Services

Anti-CD70 CAR-T In Vitro Assay Services

CD70 CAR-T Expression Test

Our CD70 CAR-T cell expression test services include a comprehensive analysis of CD70 expression levels on T cells using cutting-edge technology and state-of-the-art equipment. In addition to our CD70 CAR-T cell expression test services, we offer comprehensive reporting and interpretation of the test results. Based on the findings, our team will offer an in-depth analysis service.

CTX130 potency initially correlates with CD70 expression. Fig.2 CTX130 potency initially correlates with CD70 expression.2

CD70 CAR-T Cytokine Release Test

ELISA results showed the IFN-γ and IL-2 secretion levels by CD70 CAR. (Yang, et al., 2020) Fig.3 ELISA results showed the IFN-γ and IL-2 secretion levels by CD70 CAR.1

CD70 CAR-T In Vitro Cytotoxicity Assay

Cytokine release assays are rapid and straightforward techniques for assessing the activation of T-cells when stimulated by target cells presenting the candidate peptide. We have accumulated significant expertise in cytokine release assays, and we believe it will accelerate our clients' research progress.

The enhanced tumor-killing ability of CD70 CAR-T cells against target cells. Fig.4 The enhanced tumor-killing ability of CD70 CAR-T cells against target cells.1

CD70 CAR-T Cell Proliferation Test

Creative Biolabs provides proliferation tests to accurately evaluate the proliferation capacity of CAR-T cells in response to tumor challenges.

The proliferation of CD70-CAR-T cells measured using CFSE assay. Fig.5 The proliferation of CD70-CAR-T cells measured using CFSE assay.3

Anti-CD70 CAR-T In Vivo Assay Services

CD70 CAR-T Cell Therapy Animal Models

Our team has dedicated significant efforts to enhance the CD70 CAR-T Cell Therapy animal models. Firstly, we have developed more sophisticated and accurate models that better mimic human physiological and immune responses. These models incorporate humanized components, such as human immune cells or tissues, enabling us to better study the interactions between CAR-T cells and the human immune system.

The treatment scheme of CAR-T cells T cells and in vivo optical imaging. (Yang, et al., 2020) Fig.6 The treatment scheme of CAR-T cells T cells and in vivo optical imaging.1

Efficacy Test of CD70 CAR-T

We have implemented cutting-edge techniques and rigorous protocols to evaluate the efficacy of CAR-T in vivo.

Antitumor response of TanCAR-T cells in human subcutaneous xenograft models. Fig.7 Antitumor response of TanCAR-T cells in human subcutaneous xenograft models.1

Toxicity Evaluation of CD70 CAR-T

Creative Biolabs has been dedicated to enhancing the evaluation methods for CAR-T cell toxicity, focusing on various aspects. Firstly, we have developed sophisticated in vitro models that mimic the tumor microenvironment to better predict the potential toxic effects of CAR-T cells. These models incorporate factors such as immune cells, tumor cells, and cytokines, creating a complex and realistic environment for toxicity assessment.

Evaluation of hematologic toxicity of CD70-CAR-T cells in vivo. (Wu, et al., 2023). Fig.8 Evaluation of hematologic toxicity of CD70-CAR-T cells in vivo.3

References

  1. Yang, Meijia.; et al. "Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors." Theranostics 10.17 (2020): 7622.
  2. Dequeant, Mary Lee.; et al. "Targeting multiple solid tumor types with anti-CD70 allogeneic CAR-T cells." Cancer Research 79.13_Supplement (2019): 3184-3184.
  3. Wu, Gongqiang.; et al. "Preclinical evaluation of CD70-specific CAR T cells targeting acute myeloid leukemia." Frontiers in Immunology 14 (2023): 1093750.
  • CAR Vector Products

  • AbTCR Vector Products

  • CAR Cell Products

  • CAR Viral Particles

  • Protein

  • TriCAR Vector Products

  • CAR Animal Cells

  • CAR mRNA

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
  • CAR Vector Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
XS-1122-LX340 Anti-CD70 (X11X340) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X340 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX341 Anti-CD70 (X11X341) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X341 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX342 Anti-CD70 (X11X342) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X342 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX343 Anti-CD70 (X11X343) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X343 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX344 Anti-CD70 (X11X344) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X344 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX345 Anti-CD70 (X11X345) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X345 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX346 Anti-CD70 (X11X346) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X346 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX347 Anti-CD70 (X11X347) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X347 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX348 Anti-CD70 (X11X348) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X348 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX349 Anti-CD70 (X11X349) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X349 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX354 Anti-CD70 (X11X354) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X354 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX355 Anti-CD70 (X11X355) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X355 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX356 Anti-CD70 (X11X356) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X356 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX357 Anti-CD70 (X11X357) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X357 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX358 Anti-CD70 (X11X358) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X358 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX359 Anti-CD70 (X11X359) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X359 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX360 Anti-CD70 (X11X360) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X360 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX361 Anti-CD70 (X11X361) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X361 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX362 Anti-CD70 (X11X362) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X362 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-1122-LX363 Anti-CD70 (X11X363) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Human X11X363 Humanized scFv-CD28-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
XS-0823-LX23 Anti-hCD70 (69A7) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector Human 69A7 Adenoviral vectors   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.